LONDON (AFX) - BioProgress plc, the specialty pharma and healthcare company, said it has obtained an EU registration for Ronflux Nasal Spray as a medical device through Laboratoires Pharmaceutiques Dexo SAS, the company’s French pharmaceutical division.
